[{"AccountsPayableAndAccruedLiabilitiesCurrent_0_Q2_USD":8643000.0,"OperatingLeaseRightOfUseAsset_0_Q2_USD":1971000.0,"OperatingLeaseLiabilityNoncurrent_0_Q2_USD":1102000.0,"OperatingLeaseLiabilityCurrent_0_Q2_USD":937000.0,"OperatingIncomeLoss_2_Q2_USD":-57077000.0,"OperatingIncomeLoss_1_Q2_USD":-30206000.0,"OperatingExpenses_2_Q2_USD":57077000.0,"OperatingExpenses_1_Q2_USD":30206000.0,"NumberOfReportableSegments_2_Q2_segment":1.0,"OtherAssetsNoncurrent_0_Q2_USD":0.0,"NumberOfOperatingSegments_2_Q2_segment":1.0,"NetIncomeLoss_1_Q2_USD":-30143000.0,"NetCashProvidedByUsedInOperatingActivities_2_Q2_USD":-49908000.0,"NetCashProvidedByUsedInInvestingActivities_2_Q2_USD":33321000.0,"NetCashProvidedByUsedInFinancingActivities_2_Q2_USD":577000.0,"LiabilitiesCurrent_0_Q2_USD":24992000.0,"LiabilitiesAndStockholdersEquity_0_Q2_USD":165667000.0,"Liabilities_0_Q2_USD":26094000.0,"InterestIncomeExpenseNonoperatingNet_2_Q2_USD":142000.0,"NetIncomeLoss_2_Q2_USD":-56938000.0,"OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax_1_Q2_USD":1000.0,"OtherNonoperatingIncomeExpense_1_Q2_USD":-2000.0,"OtherNonoperatingIncomeExpense_2_Q2_USD":-3000.0,"WeightedAverageNumberOfDilutedSharesOutstanding_2_Q2_shares":93382000.0,"WeightedAverageNumberOfDilutedSharesOutstanding_1_Q2_shares":93409000.0,"StockIssuedDuringPeriodValueIssuedForServices_1_Q2_USD":448000.0,"StockholdersEquity_0_Q2_USD":139573000.0,"ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate_2_Q2_pure":0.0,"ShareBasedCompensation_2_Q2_USD":4371000.0,"RetainedEarningsAccumulatedDeficit_0_Q2_USD":-622011000.0,"ResearchAndDevelopmentExpense_2_Q2_USD":42037000.0,"ResearchAndDevelopmentExpense_1_Q2_USD":23488000.0,"PropertyPlantAndEquipmentNet_0_Q2_USD":8000.0,"ProceedsFromMaturitiesPrepaymentsAndCallsOfAvailableForSaleSecurities_2_Q2_USD":72635000.0,"ProceedsFromIncomeTaxRefunds_2_Q2_USD":1765000.0,"PrepaidExpenseAndOtherAssetsCurrent_0_Q2_USD":3806000.0,"PreferredStockValue_0_Q2_USD":0.0,"PreferredStockSharesOutstanding_0_Q2_shares":0.0,"PreferredStockSharesIssued_0_Q2_shares":0.0,"PreferredStockSharesAuthorized_0_Q2_shares":5000000.0,"PreferredStockParOrStatedValuePerShare_0_Q2_USD":0.001,"PaymentsToAcquireMarketableSecurities_2_Q2_USD":39314000.0,"InterestIncomeExpenseNonoperatingNet_1_Q2_USD":65000.0,"WeightedAverageNumberOfSharesOutstandingBasic_1_Q2_shares":93409000.0,"IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets_2_Q2_USD":-990000.0,"IncreaseDecreaseInAccruedInterestReceivableNet_2_Q2_USD":-92000.0,"CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_2_Q2_USD":-16010000.0,"CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_0_Q2_USD":50363000.0,"CashAndCashEquivalentsAtCarryingValue_0_Q2_USD":50363000.0,"Cash_0_Q2_USD":2000000.0,"AvailableForSaleSecuritiesDebtSecurities_0_Q2_USD":109519000.0,"AvailableForSaleDebtSecuritiesAmortizedCostBasis_0_Q2_USD":109516000.0,"AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax_0_Q2_USD":2000.0,"AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax_0_Q2_USD":5000.0,"CashEquivalentsAtCarryingValue_0_Q2_USD":48400000.0,"AssetsCurrent_0_Q2_USD":163688000.0,"AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_2_Q2_shares":11186000.0,"AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_1_Q2_shares":11186000.0,"AllocatedShareBasedCompensationExpense_2_Q2_USD":4371000.0,"AllocatedShareBasedCompensationExpense_1_Q2_USD":2079000.0,"AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue_1_Q2_USD":2079000.0,"AdditionalPaidInCapital_0_Q2_USD":761491000.0,"AccumulatedOtherComprehensiveIncomeLossNetOfTax_0_Q2_USD":3000.0,"AccretionAmortizationOfDiscountsAndPremiumsInvestments_2_Q2_USD":-742000.0,"Assets_0_Q2_USD":165667000.0,"ClassOfWarrantOrRightOutstanding_0_Q2_shares":3164280.0,"CommonStockParOrStatedValuePerShare_0_Q2_USD":0.001,"CommonStockSharesAuthorized_0_Q2_shares":200000000.0,"IncreaseDecreaseInAccountsPayableAndAccruedLiabilities_2_Q2_USD":-4149000.0,"IncomeTaxExpenseBenefit_2_Q2_USD":0.0,"IncomeTaxExpenseBenefit_1_Q2_USD":0.0,"IncomeTaxesReceivable_0_Q2_USD":0.0,"IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_2_Q2_USD":-56938000.0,"IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_1_Q2_USD":-30143000.0,"GeneralAndAdministrativeExpense_2_Q2_USD":15040000.0,"GeneralAndAdministrativeExpense_1_Q2_USD":6718000.0,"FairValueAssetsLevel1ToLevel2TransfersAmount_0_Q2_USD":0.0,"EarningsPerShareDiluted_2_Q2_USD":-0.61,"EarningsPerShareDiluted_1_Q2_USD":-0.32,"EarningsPerShareBasic_2_Q2_USD":-0.61,"EarningsPerShareBasic_1_Q2_USD":-0.32,"Depreciation_2_Q2_USD":18000.0,"ComprehensiveIncomeNetOfTax_2_Q2_USD":-56938000.0,"ComprehensiveIncomeNetOfTax_1_Q2_USD":-30142000.0,"CommonStockValue_0_Q2_USD":90000.0,"CommonStockSharesOutstanding_0_Q2_shares":90386770.0,"CommonStockSharesIssued_0_Q2_shares":90386770.0,"IncreaseDecreaseInIncomeTaxesReceivable_2_Q2_USD":-1765000.0,"WeightedAverageNumberOfSharesOutstandingBasic_2_Q2_shares":93382000.0,"Ticker":"ISEE","CIK":"1410939","name":"IVERIC BIO, INC.","OfficialName":"IVERIC bio Inc. Common Stock","form":"10-Q","period":"20210630","fy":"2021.0","fp":"Q2","qtrs":"0","uom":"USD","footnote":"nan","Market Cap":"1851737728.0","Country":"United States","Sector":"Health Care","Industry":"Biotechnology: Pharmaceutical Preparations","Market":"NASDAQ","SP500":"nan","filed":"20210804"}]